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Cycloastragenol, a triterpene aglycone derived from Radix 
astragali, suppresses the accumulation of cytoplasmic lipid 
droplet in 3T3-L1 adipocytes 
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Cycloastragenol (CAG), a bioactive triterpenoid sapogenin isolated from the Chinese herbal medicine 
Radix astragali, was reported to promote the phosphorylation of extracellular signal-regulated protein 
kinase (ERK). Here we investigated the effect of CAG on adipogenesis. The image-based Nile red staining 
analyses revealed that CAG dose dependently reduced cytoplasmic lipid droplet in 3T3-L1 adipocytes with 
the IC50 value of 13.0 μM. Meanwhile, cytotoxicity assay provided evidence that CAG was free of injury on 
HepG2 cells up to 60 μM. In addition, using calcium mobilization assay, we observed that CAG stimulated 
calcium influx in 3T3-L1 preadipocytes with a dose dependent trend, the EC50 value was determined as 
21.9 μM. There were proofs that elevated intracellular calcium played a vital role in suppressing adipocyte 
differentiation. The current findings demonstrated that CAG was a potential therapeutic candidate for 
alleviating obesity and hyperlipidemia. 
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